You are here
ASSUAGE PHARMACEUTICALS, INC.
UEI: N/A
# of Employees: 4
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Discovery of alpha4beta2 Nicotinic Receptor Antagonists as Alcohol Abuse Medications
Amount: $224,956.00PROJECT SUMMARY Alcohol addiction and disorders associated to excessive alcohol use are a serious public health problem in the United States and in other parts of the world Current pharmacotherapies ...
STTRPhase I2016Department of Health and Human Services National Institutes of Health -
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation
Amount: $997,167.00DESCRIPTION provided by applicant Smoking remains the number one avoidable cause of death in the United States and costs the economy tens of billions of dollars every year Current therapies includ ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation
Amount: $149,996.00DESCRIPTION (provided by applicant): Smoking remains the number one avoidable cause of death in the United States. Current therapies including nicotine replacement, inhibition of the dopamine system w ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health
